International PR

press release

Title Biotech companies leading the way with exosome human clinical trials
writer exocobio
date 2020-07-30

 Biotech companies leading the way with exosome

 human clinical trials



 A number of companies are in the preclinical phase of exosome

therapy research.

 

 In Korea, Ilias and ExoCoBio are developing exosome therapeutics.

Ilias – founded by faculty from the Korean Advance Institute of

Science and Technology – specialises in loading large protein

therapeutics into exosomes.


 It is currently carrying out preclinical research toward treating

sepsis, preterm labour and Gaucher¡¯s disease. ExoCoBio is focusing

on the native regenerative capacity of exosomes derived from

mesenchymal stem cells, including to treat atopic dermatitis.




                                                                                                     <Born2Invest> 2020. 2. 9

      URL : https://born2invest.com/articles/biotech-companies-leading-the-way-with-exosome-human-clinical-trials/

´Ù¿î·Îµå¼ö 0